Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 60.19
-0.23 (-0.38%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
| Anesthetic Products | 1.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anesthetic Products Growth | 44.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cooperative Products | 943.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Indications | 580.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Parenteral Nutrition System | 511.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Parenteral Nutrition System Growth | -16.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antiemetic for Tumors | 305.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antiemetic for Tumors Growth | 44.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Main Business | 120.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 28.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 43.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Materials | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibiotics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibiotics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hepatobiliary Digestion | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hepatobiliary Digestion Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APIs and Patented Technology | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APIs and Patented Technology Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
| China | 3.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 10.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|